Potentiation of nerve growth factor-induced neurite outgrowth by the ROCK inhibitor Y-27632: A possible role of IP3 receptors

European Journal of Pharmacology

Volumn 648, Issue 1-3, 2010, Pages 67-73

  Minase, Takahiko ^a   Ishima, Tamaki ^a   Itoh, Kanako ^a   Hashimoto, Kenji ^a  

^a CHIBA UNIVERSITY   (Japan)

Author keywords

IP3 receptor; Nerve growth factor; Neurite outgrowth; PC12 cells; Rho inhibitor; ROCK inhibitor

Indexed keywords

4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; EXOENZYME C3; FASUDIL; H 1152; INOSITOL 1,4,5 TRISPHOSPHATE RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; NERVE GROWTH FACTOR; PHOSPHOLIPASE C; RAF PROTEIN; RAS PROTEIN; RHO KINASE; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; IMMUNOCYTOCHEMISTRY; NERVE FIBER GROWTH; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RAT; SIGNAL TRANSDUCTION;

AMIDES; ANIMALS; DRUG SYNERGISM; INOSITOL 1,4,5-TRISPHOSPHATE RECEPTORS; MAP KINASE SIGNALING SYSTEM; NERVE GROWTH FACTOR; NEURITES; PC12 CELLS; PIPERAZINES; PROTEIN KINASE INHIBITORS; PYRIDINES; RATS; RECEPTOR, TRKA; RHO GTP-BINDING PROTEINS; RHO-ASSOCIATED KINASES;

EID: 77957751075     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2010.09.007     Document Type: Article

References (39)

1. Berridge M.J., Irvine R.F. Inositol phosphates and cell signalling. Nature 1989, 341:197-205.
2. Blosover S.R. Calcium signaling in growth cone migration. Cell Calcium 2005, 37:395-402.
3. Chao M.V. Neurotrophins and their receptors: a convergence point for many signaling pathways. Nat. Rev. Neurosci. 2003, 4:299-309.
4. Fujita A., Hattori Y., Takeuchi T., Kamata Y., Hata F. NGF induces neurite outgrowth via a decrease in phosphorylation of myosin light chain in PC12 cells. NeuroReport 2001, 12:3599-3602.
5. Gafni J., Munsch J.A., Lam T.H., Catlin M.C., Costa L.G., Molinski T.F., Pessah N. Xestospongins: potent membrane permeable blockers of the inositol 1, 4, 5-trisphosphate receptor. Neuron 1997, 19:723-733.
6. Gomez T.M., Zheng J.Q. The molecular basis for calcium-dependent axon pathfinding. Nat. Rev. Neurosci. 2006, 7:115-125.
7. Hashimoto K. Sigma-1 receptors and selective serotonin reuptake inhibitors: clinical implications of their relationship. Cent. Nerv. Syst. Agents Med. Chem. 2009, 9:197-204.
8. 2+ signals. Trends Cell Biol. 2004, 14:320-330.
9. Huang E.J., Reichardt L.F. Trk receptors: roles in neuronal signal transduction. Annu. Rev. Biochem. 2001, 72:609-642.
10. Iketani M., Imaizumi C., Nakamura F., Jeromin A., Mikoshiba K., Goshima Y., Takei K. Regulation of neurite outgrowth mediated by neuronal calcium sensor-1 and inositol 1, 4, 5-trisphosphate receptor in nerve growth cones. Neuroscience 2009, 161:743-752.
11. 3 receptors. Prog. Neuropsychopharmacol. Biol. Psychiatry 2008, 32:1656-1659.
12. Ishizaki T., Uehata M., Tamechika I., Keel J., Nonomura K., Maekawa M., Narumiya S. Pharmacological properties of Y-27632, a specific inhibitor of rho-associated kinases. Mol. Pharmacol. 2000, 57:976-983.
13. Jalink K., van Corven E.J., Hengeveld T., Morii N., Narumiya S., Moolenaar W.H. Inhibition of lysophosphatidate- and thrombin-induced neurite retraction and neuronal cell rounding by ADP ribosylation of the small GTP-binding protein Rho. J. Cell Biol. 1994, 126:801-810.
14. Kim Y., Seger R., Suresh Babu C.V., Hwang S.Y., Yoo Y.S. A positive role of the PI3K/Akt signaling pathway in PC12 cell differentiation. Mol. Cells 2004, 18:353-359.
15. Kimura K., Hattori S., Kabuyama Y., Shizawa Y., Takayanagi J., Nakamura S., Toki S., Matsuda Y., Onodera K., Fukui Y. Neurite outgrowth of PC12 cells is suppressed by wortmannin, a specific inhibitor of phosphatidylinositol 3-kinase. J. Biol. Chem. 1994, 269:18961-18967.
16. Kubo T., Yamashita T. Rho-ROCK inhibitors for the treatment of CNS injury. Recent Pat. CNS Drug Discov. 2007, 2:173-179.
17. Lu X.H., Dwyer D.S. Second-generation antipsychotic drugs, olanzapine, quetiapine, and clozapine enhance neurite outgrowth in PC12 cells via PI3K/AKT, ERK, and pertussis toxin-sensitive pathways. J. Mol. Neurosci. 2005, 27:43-64.
18. 2+ channel. Science 2000, 287:1647-1651.
19. Mattson M.P. Glutamate and neurotrophic factors in neuronal plasticity and disease. Ann. N.Y. Acad. Sci. 2008, 1144:97-112.
20. Mueller B.K., Mack H., Teusch N. Rho kinase, a promising drug target for neurological disorders. Nat. Rev. Drug Discov. 2005, 4:387-398.
21. Nishiki T., Narumiya S., Morii N., Yamamoto M., Fujiwara M., Kamata Y., Sakaguchi G., Kozaki S. ADP-ribosylation of the rho/rac proteins induces growth inhibition, neurite outgrowth and acetylcholine esterase in cultured PC-12 cells. Biochem. Biophys. Res. Commun. 1990, 167:265-272.
22. 3 receptors and cellular signaling pathways. PLoS ONE 2008, 3:e2558.
23. Obermeier A., Bradshaw R.A., Seedorf K., Choidas A., Schlessinger J., Ullrich A. Neuronal differentiation signals are controlled by nerve growth factor receptor/Trk binding sites for SHC and PLC-γ. EMBO J. 1994, 13:1585-1590.
24. Price R.D., Yamaji T., Matsuoka N. FK506 potentiates NGF-induced neurite outgrowth via the Ras/Raf/MAP kinase pathway. Br. J. Pharmacol. 2003, 140:825-829.
25. Price R.D., Yamaji T., Yamamoto H., Higashi Y., Hanaoka K., Yamazaki S., Ishiye M., Aramori I., Matsuoka N., Mutoh S., Yanagihara T., Gold B.G. FK1706, a novel non-immunosuppressive immunophilin: neurotrophic activity and mechanism of action. Eur. J. Pharmacol. 2005, 509:11-19.
26. Riento K., Ridley A.J. ROCKs: multifunctional kinases in cell behaviour. Nat. Rev. Mol. Cell Biol. 2003, 4:446-456.
27. Salminen A., Suuronen T., Kaarniranta K. ROCK, PAK, and Toll of synapses in Alzheimer's disease. Biochem. Biophys. Res. Commun. 2008, 371:587-590.
28. Schmandke A., Schmandke A., Strittmatter S.M. ROCK and Rho: biochemistry and neuronal functions of Rho-associated protein kinases. Neuroscientist 2007, 13:454-469.
29. Schubbert S., Shannon K., Bollag G. Hyperactive Ras in developmental disorders and cancer. Nat. Rev. Cancer 2007, 7:295-308.
30. Shin H.K., Salomone S., Ayata C. Targeting cerebrovascular Rho-kinase in stroke. Expert Opin. Ther. Targets 2008, 12:1547-1564.
31. Sofroniew M.V., Howe C.L., Mobley W.C. Nerve growth factor signaling, neuroprotection, and neural repair. Annu. Rev. Neurosci. 2001, 24:1217-1281.
32. Stephens R.M., Loeb D.M., Copeland T.D., Pawson T., Greene L.A., Kaplan D.R. Trk receptors use redundant signal transduction pathways involving SHC and PLC-gamma 1 to mediate NGF responses. Neuron 1994, 12:691-705.
33. Sugawara H., Kurosaki M., Takata M., Kurosaki T. Genetic evidence for involvement of type 1, type 2 and type 3 inositol 1, 4, 5-trisphosphate receptors in signal transduction through the B-cell antigen receptor. EMBO J. 1997, 16:3078-3088.
34. Takebayashi M., Hayashi T., Su T.P. A perspective on the new mechanism of antidepressants: neuritogenesis through sigma-1 receptors. Pharmacopsychiatry 2004, 37(Suppl 3):S208-S213.
35. Takei K., Shin R.M., Inoue T., Kato K., Mikoshiba K. Regulation of nerve growth mediated by inositol 1, 4, 5-trisphosphate receptors in growth cones. Science 1998, 282:1705-1708.
36. Tang B.L., Liou Y.C. Novel modulators of amyloid-beta precursor protein processing. J. Neurochem. 2007, 100:314-322.
37. 2+ signaling and Rho. J. Neurochem. 1996, 66:537-548.
38. Tigyi G., Fischer D.J., Sebök A., Marshall F., Dyer D.L., Miledi R. Lysophosphatidic acid-induced neurite retraction in PC12 cells: neurite-protective effects of cyclic AMP signaling. J. Neurochem. 1996, 66:549-558.
39. Uehata M., Ishizaki T., Satoh H., Ono T., Kawahara T., Morishita T., Tamakawa H., Yamagami K., Inui J., Maekawa M., Narumiya S. Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension. Nature 1997, 389:990-994.